{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:33:12Z","timestamp":1787563992287,"version":"build-2736575974"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s12015-024-10821-4","type":"journal-article","created":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T04:21:55Z","timestamp":1730694115000},"page":"304-318","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Unleashing the Power of Induced Pluripotent stem Cells in in vitro Modelling of Lesch-Nyhan Disease"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9551-2731","authenticated-orcid":false,"given":"Sundas","family":"Javed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8325-4589","authenticated-orcid":false,"given":"Marco","family":"Fersini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0016-0728","authenticated-orcid":false,"given":"Giulia","family":"Bernardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,4]]},"reference":[{"key":"10821_CR1","doi-asserted-by":"publisher","unstructured":"Saito, M. K., Osawa, M., Tsuchida, N., Shiraishi, K., Niwa, A., Woltjen, K., Asaka, I., Ogata, K., Ito, S., Kobayashi, S., et al. (2023). A disease-specific IPS cell resource for studying rare and intractable diseases. Inflamm Regen, 43,. https:\/\/doi.org\/10.1186\/S41232-023-00294-2","DOI":"10.1186\/S41232-023-00294-2"},{"key":"10821_CR2","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/J.BBRC.2015.10.014","volume":"473","author":"PR Pitrez","year":"2016","unstructured":"Pitrez, P. R., Rosa, S. C., Pra\u00e7a, C., & Ferreira, L. (2016). Vascular disease modeling using Induced Pluripotent Stem cells: Focus in Hutchinson-Gilford Progeria Syndrome. Biochemical and Biophysical Research Communications - BBRC, 473, 710\u2013718. https:\/\/doi.org\/10.1016\/J.BBRC.2015.10.014","journal-title":"Biochemical and Biophysical Research Communications - BBRC"},{"key":"10821_CR3","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/J.CELL.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131, 861\u2013872. https:\/\/doi.org\/10.1016\/J.CELL.2007.11.019","journal-title":"Cell"},{"key":"10821_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/J.BRAINRES.2015.09.023","volume":"1638","author":"Y Liu","year":"2016","unstructured":"Liu, Y., & Deng, W. (2016). Reverse Engineering Human neurodegenerative disease using pluripotent stem cell technology. Brain Research, 1638, 30\u201341. https:\/\/doi.org\/10.1016\/J.BRAINRES.2015.09.023","journal-title":"Brain Research"},{"key":"10821_CR5","doi-asserted-by":"publisher","unstructured":"Fern\u00e1ndez-Santiago, R., & Ezquerra, M. (2016). Epigenetic research of neurodegenerative disorders using patient IPSC-Based Models. Stem Cells Int 2016, 9464591, https:\/\/doi.org\/10.1155\/2016\/9464591","DOI":"10.1155\/2016\/9464591"},{"key":"10821_CR6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/J.MCP.2018.01.001","volume":"40","author":"RH Anderson","year":"2018","unstructured":"Anderson, R. H., & Francis, K. R. (2018). Modeling Rare diseases with Induced Pluripotent Stem Cell Technology. Molecular and Cellular Probes, 40, 52\u201359. https:\/\/doi.org\/10.1016\/J.MCP.2018.01.001","journal-title":"Molecular and Cellular Probes"},{"key":"10821_CR7","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.3390\/CELLS10092319","volume":"10, Page 2319","author":"MAM Aboul-Soud","year":"2021","unstructured":"Aboul-Soud, M. A. M., Alzahrani, A. J., & Mahmoud, A. (2021). Induced Pluripotent Stem cells (IPSCs)\u2014Roles in regenerative therapies, Disease Modelling and Drug Screening. Cells 2021, 10, Page 2319, 2319. https:\/\/doi.org\/10.3390\/CELLS10092319","journal-title":"Cells 2021"},{"key":"10821_CR8","doi-asserted-by":"publisher","unstructured":"Freel, B. A., Sheets, J. N., & Francis, K. R. (2020). IPSC modeling of Rare Pediatric disorders. Journal of Neuroscience Methods, 332. https:\/\/doi.org\/10.1016\/J.JNEUMETH.2019.108533","DOI":"10.1016\/J.JNEUMETH.2019.108533"},{"key":"10821_CR9","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/HUMREP\/DEG143","volume":"18","author":"G De Wert","year":"2003","unstructured":"De Wert, G., & Mummery, C. (2003). Human embryonic stem cells: Research, Ethics and Policy. Human Reproduction, 18, 672\u2013682. https:\/\/doi.org\/10.1093\/HUMREP\/DEG143","journal-title":"Human Reproduction"},{"key":"10821_CR10","doi-asserted-by":"publisher","unstructured":"Kurtz, A., Mah, N., Chen, Y., Fuhr, A., Kobold, S., Seltmann, S., & M\u00fcller, S. C. (2022). Human Pluripotent Stem Cell Registry: Operations, Role and current directions. Cell Proliferation, 55. https:\/\/doi.org\/10.1111\/CPR.13238","DOI":"10.1111\/CPR.13238"},{"key":"10821_CR11","doi-asserted-by":"publisher","unstructured":"Venugopal, N., Naik, G., Jayanna, K., Mohapatra, A., Sasinowski, F. J., Kartha, R. V., & Rajasimha, H. K. (2024). Review of methods for estimating the prevalence of rare diseases. Rare Dis Orphan Drugs J 2024;3:5. 3, N\/A-N\/A, https:\/\/doi.org\/10.20517\/RDODJ.2023.39","DOI":"10.20517\/RDODJ.2023.39"},{"key":"10821_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/D41573-019-00180-Y","volume":"19","author":"M Haendel","year":"2020","unstructured":"Haendel, M., Vasilevsky, N., Unni, D., Bologa, C., Harris, N., Rehm, H., Hamosh, A., Baynam, G., Groza, T., McMurry, J., et al. (2020). How many rare diseases are there? Nature Reviews. Drug Discovery, 19, 77\u201378. https:\/\/doi.org\/10.1038\/D41573-019-00180-Y","journal-title":"Nature Reviews. Drug Discovery"},{"key":"10821_CR13","doi-asserted-by":"publisher","first-page":"e1002966","DOI":"10.1371\/JOURNAL.PMED.1002966","volume":"16","author":"CA Rees","year":"2019","unstructured":"Rees, C. A., Pica, N., Monuteaux, M. C., & Bourgeois, F. T. (2019). Noncompletion and nonpublication of trials studying Rare diseases: A cross-sectional analysis. Plos Medicine, 16, e1002966. https:\/\/doi.org\/10.1371\/JOURNAL.PMED.1002966","journal-title":"Plos Medicine"},{"key":"10821_CR14","doi-asserted-by":"publisher","unstructured":"Baldassari, S., Musante, I., Iacomino, M., Zara, F., Salpietro, V., & Scudieri, P. (2020). Brain organoids as Model systems for Genetic Neurodevelopmental disorders. Front Cell Dev Biol, 8. https:\/\/doi.org\/10.3389\/FCELL.2020.590119","DOI":"10.3389\/FCELL.2020.590119"},{"key":"10821_CR15","doi-asserted-by":"publisher","first-page":"8290","DOI":"10.3390\/IJMS21218290","volume":"21, Page 8290","author":"E Masini","year":"2020","unstructured":"Masini, E., Loi, E., Vega-Benedetti, A. F., Carta, M., Doneddu, G., Fadda, R., & Zavattari, P. (2020). An overview of the Main Genetic, epigenetic and environmental factors involved in Autism Spectrum Disorder focusing on synaptic activity. International Journal of Molecular Sciences 2020, 21, Page 8290, 8290. https:\/\/doi.org\/10.3390\/IJMS21218290","journal-title":"International Journal of Molecular Sciences 2020"},{"key":"10821_CR16","doi-asserted-by":"publisher","first-page":"e1398","DOI":"10.1002\/WCS.1398","volume":"8","author":"H D\u2019Souza","year":"2017","unstructured":"D\u2019Souza, H., & Karmiloff-Smith, A. (2017). Neurodevelopmental disorders. Wiley Interdisciplinary Reviews. Cognitive Science, 8, e1398. https:\/\/doi.org\/10.1002\/WCS.1398","journal-title":"Wiley Interdisciplinary Reviews. Cognitive Science"},{"key":"10821_CR17","doi-asserted-by":"publisher","first-page":"787","DOI":"10.3390\/METABO13070787","volume":"13, Page 787","author":"M Camici","year":"2023","unstructured":"Camici, M., Garcia-Gil, M., Allegrini, S., Pesi, R., Bernardini, G., Micheli, V., & Tozzi, M. G. (2023). Inborn errors of Purine Salvage and Catabolism. Metabolites 2023, 13, Page 787, 787. https:\/\/doi.org\/10.3390\/METABO13070787","journal-title":"Metabolites 2023"},{"key":"10821_CR18","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/J.NEUBIOREV.2020.12.025","volume":"121","author":"KR Sabitha","year":"2021","unstructured":"Sabitha, K. R., Shetty, A. K., Upadhya, D., & Patient-Derived, I. P. S. C. (2021). Modeling of Rare Neurodevelopmental disorders: Molecular pathophysiology and prospective therapies. Neuroscience and Biobehavioral Reviews, 121, 201\u2013219. https:\/\/doi.org\/10.1016\/J.NEUBIOREV.2020.12.025","journal-title":"Neuroscience and Biobehavioral Reviews"},{"key":"10821_CR19","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/J.NEURON.2015.12.008","volume":"89","author":"JC Silbereis","year":"2016","unstructured":"Silbereis, J. C., Pochareddy, S., Zhu, Y., Li, M., & Sestan, N. (2016). The Cellular and Molecular landscapes of the developing Human Central Nervous System. Neuron, 89, 248\u2013268. https:\/\/doi.org\/10.1016\/J.NEURON.2015.12.008","journal-title":"Neuron"},{"key":"10821_CR20","doi-asserted-by":"publisher","unstructured":"Ni, P., Fan, L., Jiang, Y., Zhou, C., & Chung, S. (2023). From cells to insights: The power of human pluripotent stem cell-derived cortical interneurons in Psychiatric Disorder modeling. Frontiers in Psychiatry, 14. https:\/\/doi.org\/10.3389\/FPSYT.2023.1336085","DOI":"10.3389\/FPSYT.2023.1336085"},{"key":"10821_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.BBRC.2016.01.182","volume":"471","author":"K Li","year":"2016","unstructured":"Li, K., Kong, Y., Zhang, M., Xie, F., Liu, P., & Xu, S. (2016). Differentiation of pluripotent stem cells for Regenerative Medicine. Biochemical and Biophysical Research Communications, 471, 1\u20134. https:\/\/doi.org\/10.1016\/J.BBRC.2016.01.182","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10821_CR22","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/J.DRUDIS.2017.11.002","volume":"23","author":"RE Pogue","year":"2018","unstructured":"Pogue, R. E., Cavalcanti, D. P., Shanker, S., Andrade, R. V., Aguiar, L. R., de Carvalho, J. L., & Costa, F. F. (2018). Rare genetic diseases: Update on diagnosis, treatment and Online resources. Drug Discov Today, 23, 187\u2013195. https:\/\/doi.org\/10.1016\/J.DRUDIS.2017.11.002","journal-title":"Drug Discov Today"},{"key":"10821_CR23","doi-asserted-by":"publisher","unstructured":"Haase, F. D., Coorey, B., Riley, L., Cantrill, L. C., Tam, P. P. L., & Gold, W. A. (2021). Pre-clinical investigation of Rett Syndrome using human stem cell-based Disease models. Front Neurosci, 15. https:\/\/doi.org\/10.3389\/FNINS.2021.698812","DOI":"10.3389\/FNINS.2021.698812"},{"key":"10821_CR24","doi-asserted-by":"publisher","unstructured":"Cam\u00f5es dos Santos, J., Appleton, C., Cazaux Mateus, F., Covas, R., Bekman, E. P., & da Rocha, S. T. (2023). Stem cell models of Angelman Syndrome. Front Cell Dev Biol, 11. https:\/\/doi.org\/10.3389\/FCELL.2023.1274040","DOI":"10.3389\/FCELL.2023.1274040"},{"key":"10821_CR25","doi-asserted-by":"publisher","first-page":"101523","DOI":"10.1016\/J.SCR.2019.101523","volume":"39","author":"J Schuster","year":"2019","unstructured":"Schuster, J., Fatima, A., Sobol, M., Norradin, F. H., Laan, L., & Dahl, N. (2019). Generation of Three Human Induced Pluripotent Stem Cell (IPSC) lines from three patients with dravet syndrome carrying distinct SCN1A Gene Mutations. Stem Cell Res, 39, 101523. https:\/\/doi.org\/10.1016\/J.SCR.2019.101523","journal-title":"Stem Cell Res"},{"key":"10821_CR26","doi-asserted-by":"publisher","unstructured":"Szepanowski, L. P., Wruck, W., Kapr, J., Rossi, A., Fritsche, E., Krutmann, J., & Adjaye, J. (2024). Cockayne Syndrome Patient IPSC-Derived Brain Organoids and Neurospheres Show early transcriptional dysregulation of biological processes Associated with Brain Development and Metabolism. Cells, 13. https:\/\/doi.org\/10.3390\/CELLS13070591","DOI":"10.3390\/CELLS13070591"},{"key":"10821_CR27","doi-asserted-by":"publisher","unstructured":"Lee, A., Xu, J., Wen, Z., & Jin, P. (2022). Across dimensions: Developing 2D and 3D human IPSC-Based models of Fragile X Syndrome. Cells, 11. https:\/\/doi.org\/10.3390\/CELLS11111725","DOI":"10.3390\/CELLS11111725"},{"key":"10821_CR28","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/J.STEMCR.2018.12.011","volume":"12","author":"A di Domenico","year":"2019","unstructured":"di Domenico, A., Carola, G., Calatayud, C., Pons-Espinal, M., Mu\u00f1oz, J. P., Richaud-Patin, Y., Fernandez-Carasa, I., Gut, M., Faella, A., Parameswaran, J., et al. (2019). Patient-specific IPSC-Derived astrocytes contribute to non-cell-autonomous neurodegeneration in Parkinson\u2019s Disease. Stem Cell Reports, 12, 213\u2013229. https:\/\/doi.org\/10.1016\/J.STEMCR.2018.12.011","journal-title":"Stem Cell Reports"},{"key":"10821_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/J.SEMCDB.2020.05.022","volume":"111","author":"A Atamian","year":"2021","unstructured":"Atamian, A., Cord\u00f3n-Barris, L., & Quadrato, G. (2021). Taming human brain Organoids one cell at a time. Seminars in Cell & Developmental Biology, 111, 23\u201331. https:\/\/doi.org\/10.1016\/J.SEMCDB.2020.05.022","journal-title":"Seminars in Cell & Developmental Biology"},{"key":"10821_CR30","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/J.JBIOSC.2019.10.004","volume":"129","author":"K Yoshioka","year":"2020","unstructured":"Yoshioka, K., Ito, A., Kawabe, Y., & Kamihira, M. (2020). Novel Neuromuscular Junction Model in 2D and 3D myotubes co-cultured with Induced Pluripotent Stem cell-derived motor neurons. Journal of Bioscience and Bioengineering, 129, 486\u2013493. https:\/\/doi.org\/10.1016\/J.JBIOSC.2019.10.004","journal-title":"Journal of Bioscience and Bioengineering"},{"key":"10821_CR31","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1039\/C5LC00180C","volume":"15","author":"EL Moreno","year":"2015","unstructured":"Moreno, E. L., Hachi, S., Hemmer, K., Trietsch, S. J., Baumuratov, A. S., Hankemeier, T., Vulto, P., Schwamborn, J. C., & Fleming, R. M. T. (2015). Differentiation of neuroepithelial stem cells into functional dopaminergic neurons in 3D microfluidic cell culture. Lab on a Chip, 15, 2419\u20132428. https:\/\/doi.org\/10.1039\/C5LC00180C","journal-title":"Lab on a Chip"},{"key":"10821_CR32","doi-asserted-by":"publisher","first-page":"12543","DOI":"10.1073\/PNAS.0404700101\/SUPPL_FILE\/04700FIG6.JPG","volume":"101","author":"AL Perrier","year":"2004","unstructured":"Perrier, A. L., Tabar, V., Barberi, T., Rubio, M. E., Bruses, J., Topf, N., Harrison, N. L., & Studer, L. (2004). Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci U S A, 101, 12543\u201312548. https:\/\/doi.org\/10.1073\/PNAS.0404700101\/SUPPL_FILE\/04700FIG6.JPG","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10821_CR33","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/J.BIOPSYCH.2017.09.021","volume":"83","author":"FB Russo","year":"2018","unstructured":"Russo, F. B., Freitas, B. C., Pignatari, G. C., Fernandes, I. R., Sebat, J., Muotri, A. R., & Beltr\u00e3o-Braga, P. C. B. (2018). Modeling the interplay between neurons and astrocytes in Autism using Human Induced Pluripotent Stem cells. Biological Psychiatry, 83, 569\u2013578. https:\/\/doi.org\/10.1016\/J.BIOPSYCH.2017.09.021","journal-title":"Biological Psychiatry"},{"key":"10821_CR34","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/BIT.28606","volume":"121","author":"P Acharya","year":"2024","unstructured":"Acharya, P., Choi, N. Y., Shrestha, S., Jeong, S., & Lee, M. Y. (2024). Brain organoids: A Revolutionary Tool for modeling neurological disorders and Development of therapeutics. Biotechnology and Bioengineering, 121, 489\u2013506. https:\/\/doi.org\/10.1002\/BIT.28606","journal-title":"Biotechnology and Bioengineering"},{"key":"10821_CR35","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1126\/SCIENCE.155.3770.1682","volume":"155","author":"JE Seegmiller","year":"1967","unstructured":"Seegmiller, J. E., Rosenbloom, F. M., & Kelley, W. N. (1967). Enzyme defect Associated with a sex-linked human neurological disorder and excessive purine synthesis. Science (1979), 155, 1682\u20131684. https:\/\/doi.org\/10.1126\/SCIENCE.155.3770.1682","journal-title":"Science (1979)"},{"key":"10821_CR36","doi-asserted-by":"publisher","unstructured":"Zoref-Shani, E., Feinstein, S., Frishberg, Y., Bromberg, Y., & Sperling, O. (2000). Kelley-Seegmiller syndrome due to a unique variant of hypoxanthine-guanine phosphoribosyltransferase: Reduced affinity for 5-Phosphoribosyl-1-Pyrophosphate manifested only at low, physiological substrate concentrations. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1500, 197\u2013203, https:\/\/doi.org\/10.1016\/S0925-4439(99)00103-9","DOI":"10.1016\/S0925-4439(99)00103-9"},{"key":"10821_CR37","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/J.YMGME.2005.01.005","volume":"85","author":"PA Dawson","year":"2005","unstructured":"Dawson, P. A., Gordon, R. B., Keough, D. T., & Emmerson, B. T. (2005). Normal HPRT Coding Region in a male with gout due to HPRT Deficiency. Molecular Genetics and Metabolism, 85, 78\u201380. https:\/\/doi.org\/10.1016\/J.YMGME.2005.01.005","journal-title":"Molecular Genetics and Metabolism"},{"key":"10821_CR38","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/15257771003738675","volume":"29","author":"MG Garcia","year":"2010","unstructured":"Garcia, M. G., Torres, R. J., & Puig, J. G. (2010). Methylation status of HPRT1 promoter in HPRT Deficiency with normal Coding Region. Nucleosides, Nucleotides & Nucleic Acids, 29, 301\u2013305. https:\/\/doi.org\/10.1080\/15257771003738675","journal-title":"Nucleosides, Nucleotides & Nucleic Acids"},{"key":"10821_CR39","doi-asserted-by":"publisher","unstructured":"Nguyen, K., Naviaux, R., & Paik, K. (2012). and, W.N.-M.G.; undefined Lesch\u2013Nyhan syndrome: MRNA expression of HPRT in patients with enzyme proven deficiency of HPRT and normal HPRT coding region of the DNA. Elsevier 2012, https:\/\/doi.org\/10.1016\/j.ymgme.2012.06.003","DOI":"10.1016\/j.ymgme.2012.06.003"},{"key":"10821_CR40","unstructured":"Lesch-Nyhan disease and its variants | The Online metabolic and molecular bases of inherited disease | OMMBID | McGraw Hill Medical. Available online: https:\/\/ommbid.mhmedical.com\/content.aspx?sectionid=225089443&bookid=2709 (accessed on 26 March 2024)."},{"key":"10821_CR41","doi-asserted-by":"publisher","unstructured":"Mccarthy, G. T., Green, E. M., Ogunbona, O., Simmonds, H. A., & Fairbanks, Pountney, L., Bryant, T, Elizabeth A.\u00a0(2011). Population study of Lesch\u2013Nyhan disease in the UK. Wiley Online Library 53, 34\u201339, https:\/\/doi.org\/10.1111\/j.1469-8749.2010.03786.x","DOI":"10.1111\/j.1469-8749.2010.03786.x"},{"key":"10821_CR42","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/JMD2.12100","volume":"52","author":"A Bozano","year":"2020","unstructured":"Bozano, A., Schiaffino, A., Spessa, A., Valeriani, F., Mancinelli, R., Micheli, V., & Dolcetta, D. (2020). Description of the Lesch-Nyhan Neurobehavioral Disorder and its management through Participant Observation of three young individuals. JIMD Rep, 52, 63\u201371. https:\/\/doi.org\/10.1002\/JMD2.12100","journal-title":"JIMD Rep"},{"key":"10821_CR43","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/00005792-200103000-00003","volume":"80","author":"JG Puig","year":"2001","unstructured":"Puig, J. G., Torres, R. J., Mateos, F. A., Ramos, T. H., Arcas, J. M., Bu\u00f1o, A. S., & O\u2019Neill, P. (2001). The Spectrum of Hypoxanthine-Guanine Phosphoribosyltransferase (HPRT) Deficiency. Clinical experience based on 22 patients from 18 Spanish families. Medicine, 80, 102\u2013112. https:\/\/doi.org\/10.1097\/00005792-200103000-00003","journal-title":"Medicine"},{"key":"10821_CR44","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1017\/S0012162205001374","volume":"47","author":"DJ Schretlen","year":"2005","unstructured":"Schretlen, D. J., Ward, J., Meyer, S. M., Yun, J., Puig, J. G., Nyhan, W. L., Jinnah, H. A., & Harris, J. C. (2005). Behavioral aspects of Lesch-Nyhan Disease and its variants. Dev Med Child Neurol, 47, 673\u2013677. https:\/\/doi.org\/10.1017\/S0012162205001374","journal-title":"Dev Med Child Neurol"},{"key":"10821_CR45","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1017\/S0012162206002015","volume":"48","author":"VK Neychev","year":"2006","unstructured":"Neychev, V. K., & Jinnah, H. A. (2006). Sudden death in Lesch-Nyhan Disease. Dev Med Child Neurol, 48, 923\u2013926. https:\/\/doi.org\/10.1017\/S0012162206002015","journal-title":"Dev Med Child Neurol"},{"key":"10821_CR46","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/S11926-011-0231-5","volume":"14","author":"RJ Torres","year":"2012","unstructured":"Torres, R. J., Puig, J. G., & Jinnah, H. A. (2012). Update on the phenotypic spectrum of Lesch-Nyhan Disease and its attenuated variants. Current Rheumatology Reports, 14, 189\u2013194. https:\/\/doi.org\/10.1007\/S11926-011-0231-5","journal-title":"Current Rheumatology Reports"},{"key":"10821_CR47","doi-asserted-by":"crossref","unstructured":"Fu, R., Ceballos-Picot, I., Torres, R., & Brain, L. L. (2014). undefined Genotype\u2013Phenotype correlations in neurogenetics: Lesch-Nyhan disease as a model disorder. academic.oup.com.","DOI":"10.1093\/brain\/awt202"},{"key":"10821_CR48","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/J.YMGME.2014.11.001","volume":"114","author":"R Fu","year":"2015","unstructured":"Fu, R., Sutcliffe, D., Zhao, H., Huang, X., Schretlen, D. J., Benkovic, S., & Jinnah, H. A. (2015). Clinical severity in Lesch-Nyhan Disease: The role of residual enzyme and compensatory pathways. Molecular Genetics and Metabolism, 114, 55\u201361. https:\/\/doi.org\/10.1016\/J.YMGME.2014.11.001","journal-title":"Molecular Genetics and Metabolism"},{"key":"10821_CR49","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/S10545-015-9869-X","volume":"39","author":"DJ Schretlen","year":"2016","unstructured":"Schretlen, D. J., Callon, W., Ward, R. E., Fu, R., Ho, T., Gordon, B., Harris, J. C., & Jinnah, H. A. (2016). Do clinical features of Lesch-Nyhan Disease correlate more closely with hypoxanthine or guanine recycling? Journal of Inherited Metabolic Disease, 39, 85\u201391. https:\/\/doi.org\/10.1007\/S10545-015-9869-X","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10821_CR50","doi-asserted-by":"publisher","unstructured":"Terkeltaub, R., Bushinsky, D. A., & Becker, M. A. (2006). Recent developments in our understanding of the renal basis of Hyperuricemia and the development of Novel Antihyperuricemic therapeutics. Arthritis Res Ther, 8(Suppl 1). https:\/\/doi.org\/10.1186\/AR1909","DOI":"10.1186\/AR1909"},{"key":"10821_CR51","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/J.METABOL.2007.04.013","volume":"56","author":"RJ Torres","year":"2007","unstructured":"Torres, R. J., Prior, C., & Puig, J. G. (2007). Efficacy and safety of Allopurinol in patients with Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency. Metabolism, 56, 1179\u20131186. https:\/\/doi.org\/10.1016\/J.METABOL.2007.04.013","journal-title":"Metabolism"},{"key":"10821_CR52","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1042\/BJ20020148","volume":"366","author":"LD Fairbanks","year":"2002","unstructured":"Fairbanks, L. D., Jacomelli, G., Micheli, V., Slade, T., & Simmonds, H. A. (2002). Severe pyridine nucleotide depletion in fibroblasts from Lesch-Nyhan patients. The Biochemical Journal, 366, 265\u2013272. https:\/\/doi.org\/10.1042\/BJ20020148","journal-title":"The Biochemical Journal"},{"key":"10821_CR53","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1017\/S001216220300032X","volume":"45","author":"KL Robey","year":"2003","unstructured":"Robey, K. L., Reck, J. F., Giacomini, K. D., Barabas, G., & Eddey, G. E. (2003). Modes and patterns of self-mutilation in persons with Lesch-Nyhan Disease. Dev Med Child Neurol, 45, 167\u2013171. https:\/\/doi.org\/10.1017\/S001216220300032X","journal-title":"Dev Med Child Neurol"},{"key":"10821_CR54","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1212\/WNL.0000000000001128","volume":"84","author":"DJ Schretlen","year":"2015","unstructured":"Schretlen, D. J., Varvaris, M., Vannorsdall, T. D., Gordon, B., Harris, J. C., & Jinnah, H. A. (2015). Brain White Matter volume abnormalities in Lesch-Nyhan Disease and its variants. Neurology, 84, 190\u2013196. https:\/\/doi.org\/10.1212\/WNL.0000000000001128","journal-title":"Neurology"},{"key":"10821_CR55","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1093\/BRAIN\/AWL056","volume":"129","author":"HA Jinnah","year":"2006","unstructured":"Jinnah, H. A., Visser, J. E., Harris, J. C., Verdu, A., Larovere, L., Ceballos-Picot, I., Gonzalez-Alegre, P., Neychev, V., Torres, R. J., Dulac, O., et al. (2006). Delineation of the Motor disorder of Lesch-Nyhan Disease. Brain, 129, 1201\u20131217. https:\/\/doi.org\/10.1093\/BRAIN\/AWL056","journal-title":"Brain"},{"key":"10821_CR56","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1111\/J.1471-4159.2007.04472.X","volume":"101","author":"TL Shirley","year":"2007","unstructured":"Shirley, T. L., Lewers, J. C., Egami, K., Majumdar, A., Kelly, M., Ceballos-Picot, I., Seidman, M. M., & Jinnah, H. A. (2007). A human neuronal tissue culture model for Lesch-Nyhan Disease. Journal of Neurochemistry, 101, 841\u2013853. https:\/\/doi.org\/10.1111\/J.1471-4159.2007.04472.X","journal-title":"Journal of Neurochemistry"},{"key":"10821_CR57","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2478\/MEDU-2018-0002","volume":"1","author":"V Micheli","year":"2018","unstructured":"Micheli, V., Bertelli, M., Jacomelli, G., Santucci, A., & Bernardini, G. (2018). Lesch-Nyhan Disease: A rare disorder with many unresolved aspects. Medical University, 1, 13\u201324. https:\/\/doi.org\/10.2478\/MEDU-2018-0002","journal-title":"Medical University"},{"key":"10821_CR58","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/J.DDMOD.2019.10.004","volume":"31","author":"V Micheli","year":"2020","unstructured":"Micheli, V., Jacomelli, G., Santucci, A., & Bernardini, G. (2020). Animal and cell models for Lesch-Nyhan Syndrome. Drug Discov Today Dis Models, 31, 45\u201357. https:\/\/doi.org\/10.1016\/J.DDMOD.2019.10.004","journal-title":"Drug Discov Today Dis Models"},{"key":"10821_CR59","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0022-3565(25)24464-0","volume":"244","author":"H Criswell","year":"1988","unstructured":"Criswell, H., Mueller, R. A., & Breese, G. R. (1988). Assessment of purine-dopamine interactions in 6-Hydroxydopamine-lesioned rats: Evidence for pre- and postsynaptic influences by Adenosine. Journal of Pharmacology and Experimental Therapeutics, 244, 493\u2013500.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10821_CR60","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.1111\/J.1471-4159.1993.TB03488.X","volume":"60","author":"HA Jinnah","year":"1993","unstructured":"Jinnah, H. A., Page, T., & Friedmann, T. (1993). Brain purines in a genetic mouse model of Lesch-Nyhan Disease. Journal of Neurochemistry, 60, 2036\u20132045. https:\/\/doi.org\/10.1111\/J.1471-4159.1993.TB03488.X","journal-title":"Journal of Neurochemistry"},{"key":"10821_CR61","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1046\/J.1471-4159.1999.0720225.X","volume":"72","author":"HA Jinnah","year":"1999","unstructured":"Jinnah, H. A., Jones, M. D., Wojcik, B. E., Rothstein, J. D., Hess, E. J., Friedmann, T., & Breese, G. R. (1999). Influence of age and strain on Striatal dopamine loss in a genetic mouse model of Lesch-Nyhan Disease. Journal of Neurochemistry, 72, 225\u2013229. https:\/\/doi.org\/10.1046\/J.1471-4159.1999.0720225.X","journal-title":"Journal of Neurochemistry"},{"key":"10821_CR62","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/S0165-0173(99)00094-6","volume":"32","author":"JE Visser","year":"2000","unstructured":"Visser, J. E., B\u00e4r, P. R., & Jinnah, H. A. (2000). Lesch-Nyhan Disease and the basal ganglia. Brain Research Reviews, 32, 449\u2013475. https:\/\/doi.org\/10.1016\/S0165-0173(99)00094-6","journal-title":"Brain Research Reviews"},{"key":"10821_CR63","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/J.PEDIATRNEUROL.2024.03.020","volume":"155","author":"JE Visser","year":"2024","unstructured":"Visser, J. E., Chorin, O., & Jinnah, H. A. (2024). Very early levodopa may prevent Self-Injury in Lesch-Nyhan Disease. Pediatric Neurology, 155, 156\u2013159. https:\/\/doi.org\/10.1016\/J.PEDIATRNEUROL.2024.03.020","journal-title":"Pediatric Neurology"},{"key":"10821_CR64","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/J.NBD.2007.01.010","volume":"26","author":"K Egami","year":"2007","unstructured":"Egami, K., Yitta, S., Kasim, S., Lewers, J. C., Roberts, R. C., Lehar, M., & Jinnah, H. A. (2007). Basal ganglia dopamine loss due to defect in Purine Recycling. Neurobiology of Diseases, 26, 396\u2013407. https:\/\/doi.org\/10.1016\/J.NBD.2007.01.010","journal-title":"Neurobiology of Diseases"},{"key":"10821_CR65","doi-asserted-by":"publisher","first-page":"e74967","DOI":"10.1371\/JOURNAL.PONE.0074967","volume":"8","author":"TH Kang","year":"2013","unstructured":"Kang, T. H., Park, Y., Bader, J. S., & Friedmann, T. (2013). The Housekeeping Gene Hypoxanthine Guanine phosphoribosyltransferase (HPRT) regulates multiple Developmental and metabolic pathways of murine embryonic stem cell neuronal differentiation. PLoS One, 8, e74967. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0074967","journal-title":"PLoS One"},{"key":"10821_CR66","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1093\/HMG\/DDP164","volume":"18","author":"I Ceballos-Picot","year":"2009","unstructured":"Ceballos-Picot, I., Mockel, L., Potier, M. C., Dauphinot, L., Shirley, T. L., Torero-Ibad, R., Fuchs, J., & Jinnah, H. A. (2009). Hypoxanthine-Guanine Phosphoribosyl Transferase regulates early developmental programming of dopamine neurons: Implications for Lesch-Nyhan Disease Pathogenesis. Human Molecular Genetics, 18, 2317\u20132327. https:\/\/doi.org\/10.1093\/HMG\/DDP164","journal-title":"Human Molecular Genetics"},{"key":"10821_CR67","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/ANA.24191","volume":"76","author":"M G\u00f6ttle","year":"2014","unstructured":"G\u00f6ttle, M., Prudente, C. N., Fu, R., Sutcliffe, D., Pang, H., Cooper, D., Veledar, E., Glass, J. D., Gearing, M., Visser, J. E., et al. (2014). Loss of dopamine phenotype among midbrain neurons in Lesch\u2013Nyhan Disease. Annals of Neurology, 76, 95\u2013107. https:\/\/doi.org\/10.1002\/ANA.24191","journal-title":"Annals of Neurology"},{"key":"10821_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/S00018-022-04326-X\/FIGURES\/8","volume":"79","author":"JS Witteveen","year":"2022","unstructured":"Witteveen, J. S., Loopstok, S. R., Ballesteros, L. L., Boonstra, A., van Bakel, N. H. M., van Boekel, W. H. P., Martens, G. J. M., Visser, J. E., & Kolk, S. M. (2022). HGprt Deficiency disrupts Dopaminergic Circuit Development in a genetic mouse model of Lesch\u2013Nyhan Disease. Cellular and Molecular Life Sciences, 79, 1\u201319. https:\/\/doi.org\/10.1007\/S00018-022-04326-X\/FIGURES\/8","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"Suppl 3","key":"10821_CR69","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1289\/EHP.00108S3409","volume":"108","author":"WL Nyhan","year":"2000","unstructured":"Nyhan, W. L. (2000). Dopamine function in Lesch-Nyhan Disease. Environmental Health Perspectives, 108(Suppl 3), 409\u2013411. https:\/\/doi.org\/10.1289\/EHP.00108S3409","journal-title":"Environmental Health Perspectives"},{"key":"10821_CR70","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1111\/J.1651-2227.1976.TB04906.X","volume":"65","author":"G HAGBERG","year":"1976","unstructured":"HAGBERG, G., HAGBERG, B., & OLOW, I. (1976). The changing Panorama of Cerebral Palsy in Sweden 1954\u20131970. III. The importance of Foetal Deprivation of Supply. Acta Paediatr Scand, 65, 403\u2013408. https:\/\/doi.org\/10.1111\/J.1651-2227.1976.TB04906.X","journal-title":"Acta Paediatr Scand"},{"key":"10821_CR71","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/978-1-4615-2584-4_76\/COVER","volume":"370","author":"T Page","year":"1995","unstructured":"Page, T., Barshop, B., Yu, A. L., & Nyhan, W. L. (1995). Treatment of Lesch-Nyhan syndrome with AICAR. Advances in Experimental Medicine and Biology, 370, 353\u2013356. https:\/\/doi.org\/10.1007\/978-1-4615-2584-4_76\/COVER","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"10821_CR72","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/J.CELL.2008.07.041","volume":"134","author":"IH Park","year":"2008","unstructured":"Park, I. H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M. W., Cowan, C., Hochedlinger, K., & Daley, G. Q. (2008). Disease-specific induced pluripotent. Stem Cells Cell, 134, 877\u2013886. https:\/\/doi.org\/10.1016\/J.CELL.2008.07.041","journal-title":"Stem Cells Cell"},{"key":"10821_CR73","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1093\/HMG\/DDQ072","volume":"19","author":"S Cristini","year":"2010","unstructured":"Cristini, S., Navone, S., Canzi, L., Acerbi, F., Ciusani, E., Hladnik, U., de Gemmis, P., Alessandri, G., Colombo, A., Parati, E., et al. (2010). Human neural stem cells: A Model System for the study of Lesch-Nyhan Disease Neurological aspects. Human Molecular Genetics, 19, 1939\u20131950. https:\/\/doi.org\/10.1093\/HMG\/DDQ072","journal-title":"Human Molecular Genetics"},{"key":"10821_CR74","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/J.STEM.2012.02.014","volume":"10","author":"S Mekhoubad","year":"2012","unstructured":"Mekhoubad, S., Bock, C., De Boer, A. S., Kiskinis, E., Meissner, A., & Eggan, K. (2012). Erosion of Dosage Compensation impacts Human IPSC Disease modeling. Cell Stem Cell, 10, 595\u2013609. https:\/\/doi.org\/10.1016\/J.STEM.2012.02.014","journal-title":"Cell Stem Cell"},{"key":"10821_CR75","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1080\/15257770.2014.880477","volume":"33","author":"L Dauphinot","year":"2014","unstructured":"Dauphinot, L., Mockel, L., Cahu, J., Jinnah, H. A., Ledroit, M., Potier, M. C., & Ceballos-Picot, I. (2014). Transcriptomic Approach to Lesch-Nyhan Disease. Nucleosides, Nucleotides & Nucleic Acids, 33, 208\u2013217. https:\/\/doi.org\/10.1080\/15257770.2014.880477","journal-title":"Nucleosides, Nucleotides & Nucleic Acids"},{"key":"10821_CR76","doi-asserted-by":"publisher","unstructured":"Ruillier, V., Tournois, J., Boissart, C., Lasbareilles, M., Mah\u00e9, G., Chatrousse, L., Cailleret, M., Peschanski, M., & Benchoua, A. (2020). Rescuing compounds for Lesch-Nyhan Disease identified using stem cell-based phenotypic screening. JCI Insight, 5. https:\/\/doi.org\/10.1172\/JCI.INSIGHT.132094","DOI":"10.1172\/JCI.INSIGHT.132094"},{"key":"10821_CR77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-87955-9","volume":"11","author":"DJ Sutcliffe","year":"2021","unstructured":"Sutcliffe, D. J., Dinasarapu, A. R., Visser, J. E., Hoed, J., Seifar, F., Joshi, P., Ceballos-Picot, I., Sardar, T., Hess, E. J., Sun, Y. V., et al. (2021). Induced Pluripotent Stem cells from subjects with Lesch-Nyhan Disease. Scientific Reports, 11, 1\u201315. https:\/\/doi.org\/10.1038\/s41598-021-87955-9","journal-title":"Scientific Reports"},{"key":"10821_CR78","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/J.STEMCR.2021.06.003","volume":"16","author":"S Bell","year":"2021","unstructured":"Bell, S., McCarty, V., Peng, H., Jefri, M., Hettige, N., Antonyan, L., Crapper, L., O\u2019Leary, L. A., Zhang, X., Zhang, Y., et al. (2021). Lesch-Nyhan Disease Causes Impaired Energy Metabolism and reduced developmental potential in midbrain dopaminergic cells. Stem Cell Reports, 16, 1749\u20131762. https:\/\/doi.org\/10.1016\/J.STEMCR.2021.06.003","journal-title":"Stem Cell Reports"},{"key":"10821_CR79","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1080\/01677063.2022.2129632","volume":"36","author":"AR Dinasarapu","year":"2022","unstructured":"Dinasarapu, A. R., Sutcliffe, D. J., Seifar, F., Visser, J. E., & Jinnah, H. A. (2022). Abnormalities of neural stem cells in Lesch\u2013Nyhan Disease. Journal of Neurogenetics, 36, 81\u201387. https:\/\/doi.org\/10.1080\/01677063.2022.2129632","journal-title":"Journal of Neurogenetics"},{"key":"10821_CR80","doi-asserted-by":"publisher","first-page":"103287","DOI":"10.1016\/J.SCR.2023.103287","volume":"74","author":"Y Li","year":"2024","unstructured":"Li, Y., Zhang, H., Guan, J., Wang, B., Zhang, H., Liu, Y., & Gai, Z. (2024). Generation of an IPSC line (SDQLCHi030-A) derived from PBMCs of a patient with Lesch-Nyhan Syndrome caused by HPRT1 mutation. Stem Cell Res, 74, 103287. https:\/\/doi.org\/10.1016\/J.SCR.2023.103287","journal-title":"Stem Cell Res"},{"key":"10821_CR81","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1634\/STEMCELLS.22-4-635","volume":"22","author":"A Urbach","year":"2004","unstructured":"Urbach, A., Schuldiner, M., & Benvenisty, N. (2004). Modeling for Lesch-Nyhan Disease by Gene Targeting in Human Embryonic Stem cells. Stem Cells, 22, 635\u2013641. https:\/\/doi.org\/10.1634\/STEMCELLS.22-4-635","journal-title":"Stem Cells"},{"key":"10821_CR82","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1073\/PNAS.1118067109\/-\/DCSUPPLEMENTAL","volume":"109","author":"L Mastrangelo","year":"2012","unstructured":"Mastrangelo, L., Kim, J. E., Miyanohara, A., Kang, T. H., & Friedmann, T. (2012). Purinergic Signaling in Human pluripotent stem cells is regulated by the Housekeeping Gene Encoding Hypoxanthine Guanine Phosphoribosyltransferase. Proc Natl Acad Sci U S A, 109, 3377\u20133382. https:\/\/doi.org\/10.1073\/PNAS.1118067109\/-\/DCSUPPLEMENTAL","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10821_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2164-14-773\/FIGURES\/4","volume":"14","author":"S Frank","year":"2013","unstructured":"Frank, S., Skryabin, B. V., Greber, B. A., & Modified (2013). TALEN-Based system for robust generation of knock-out human pluripotent stem cell lines and Disease models. Bmc Genomics, 14, 1\u20139. https:\/\/doi.org\/10.1186\/1471-2164-14-773\/FIGURES\/4","journal-title":"Bmc Genomics"},{"key":"10821_CR84","doi-asserted-by":"publisher","unstructured":"Boissart, C., Chatrousse, L., Poullion, T., El-Kassar, L., Giraud-Triboult, K., & Benchoua, A. (2023). CRISPR\/Cas9-Mediated generation of human embryonic stem cell sub-lines with HPRT1 gene knockout to Model Lesch Nyhan Disease. Stem Cell Res, 71. https:\/\/doi.org\/10.1016\/J.SCR.2023.103144","DOI":"10.1016\/J.SCR.2023.103144"},{"key":"10821_CR85","doi-asserted-by":"publisher","unstructured":"Boissart, C., Lasbareilles, M., Tournois, J., Chatrousse, L., Poullion, T., & Benchoua, A. (2023). Identification of signaling pathways modifying human dopaminergic Neuron Development using a pluripotent stem cell-based high-throughput screening automated System: Purinergic pathways as a proof-of-Principle. Frontiers in Pharmacology, 14. https:\/\/doi.org\/10.3389\/FPHAR.2023.1152180","DOI":"10.3389\/FPHAR.2023.1152180"},{"key":"10821_CR86","doi-asserted-by":"publisher","unstructured":"Westphal, M., Panza, P., Kastenhuber, E., Wehrle, J., & Driever, W. (2022). Wnt\/\u03b2-Catenin signaling promotes neurogenesis in the diencephalospinal dopaminergic system of embryonic zebrafish. Scientific Reports 2022 12:1 12, 1\u201319, https:\/\/doi.org\/10.1038\/s41598-022-04833-8","DOI":"10.1038\/s41598-022-04833-8"},{"key":"10821_CR87","doi-asserted-by":"publisher","unstructured":"Kang, T. H., Guibinga, G. H., & Friedmann, T. H. P. R. T. (2011). Deficiency Coordinately dysregulates Canonical wnt and Presenilin-1 signaling: A Neuro-Developmental Regulatory Role for a housekeeping gene? PLoS One, 6. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0016572","DOI":"10.1371\/JOURNAL.PONE.0016572"},{"key":"10821_CR88","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1007\/S10545-015-9854-4\/FIGURES\/4","volume":"38","author":"RJ Torres","year":"2015","unstructured":"Torres, R. J., & Puig, J. G. (2015). Hypoxanthine deregulates genes involved in early neuronal development. Implications in Lesch-Nyhan Disease Pathogenesis. Journal of Inherited Metabolic Disease, 38, 1109\u20131118. https:\/\/doi.org\/10.1007\/S10545-015-9854-4\/FIGURES\/4","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10821_CR89","doi-asserted-by":"publisher","unstructured":"Volpato, V., & Webber, C. (2020). Addressing variability in IPSC-Derived models of Human Disease: Guidelines to promote reproducibility. DMM Disease Models and Mechanisms, 13. https:\/\/doi.org\/10.1242\/DMM.042317\/223104","DOI":"10.1242\/DMM.042317\/223104"},{"key":"10821_CR90","doi-asserted-by":"publisher","unstructured":"Benchoua, A., Lasbareilles, M., & Tournois, J. (2021). Contribution of human pluripotent stem cell-based models to Drug Discovery for Neurological disorders. Cells, 10. https:\/\/doi.org\/10.3390\/CELLS10123290","DOI":"10.3390\/CELLS10123290"},{"key":"10821_CR91","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1007\/S10545-012-9470-5","volume":"35","author":"MG Garc\u00eda","year":"2012","unstructured":"Garc\u00eda, M. G., Puig, J. G., Torres, R. J., & Adenosine (2012). Dopamine and serotonin receptors Imbalance in lymphocytes of Lesch-Nyhan patients. Journal of Inherited Metabolic Disease, 35, 1129\u20131135. https:\/\/doi.org\/10.1007\/S10545-012-9470-5","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10821_CR92","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/S0024-3205(99)00205-2","volume":"64","author":"V Micheli","year":"1999","unstructured":"Micheli, V., Sestini, S., Rocchigiani, M., Jacomelli, G., Manzoni, F., Peruzzi, L., Gathof, B. S., Zammarchi, E., & Pompucci, G. (1999). Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency and Erythrocyte Synthesis of Pyridine Coenzymes. Life Sciences, 64, 2479\u20132487. https:\/\/doi.org\/10.1016\/S0024-3205(99)00205-2","journal-title":"Life Sciences"},{"key":"10821_CR93","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1097\/00001756-200006260-00006","volume":"11","author":"R Pesi","year":"2000","unstructured":"Pesi, R., Micheli, V., Jacomelli, G., Peruzzi, L., Camici, M., Garcia-Gil, M., Allegrini, S., & Tozzi, M. G. (2000). Cytosolic 5\u2019-Nucleotidase hyperactivity in erythrocytes of Lesch-Nyhan Syndrome patients. Neuroreport, 11, 1827\u20131831. https:\/\/doi.org\/10.1097\/00001756-200006260-00006","journal-title":"Neuroreport"},{"key":"10821_CR94","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1042\/CS0800191","volume":"80","author":"HA Simmonds","year":"1991","unstructured":"Simmonds, H. A., Reiter, S., Davies, P. M., & Cameron, J. S. (1991). Orotidine Accumulation in Human erythrocytes during Allopurinol Therapy: Association with high urinary oxypurinol-7-Riboside concentrations in renal failure and in the Lesch-Nyhan Syndrome. Clin Sci (Lond), 80, 191\u2013197. https:\/\/doi.org\/10.1042\/CS0800191","journal-title":"Clin Sci (Lond)"},{"key":"10821_CR95","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1042\/CS0780239","volume":"78","author":"V Micheli","year":"1990","unstructured":"Micheli, V., Simmonds, H. A., & Ricci, C. (1990). Regulation of Nicotinamide-Adenine Dinucleotide synthesis in Erythrocytes of patients with Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency and a patient with Phosphoribosylpyrophosphate Synthetase Superactivity. Clinical Science, 78, 239\u2013245. https:\/\/doi.org\/10.1042\/CS0780239","journal-title":"Clinical Science"},{"key":"10821_CR96","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1136\/ADC.62.4.385","volume":"62","author":"HA Simmonds","year":"1987","unstructured":"Simmonds, H. A., Fairbanks, L. D., Morris, G. S., Morgan, G., Watson, A. R., Timms, P., & Singh, B. (1987). Central Nervous System Dysfunction and Erythrocyte Guanosine Triphosphate Depletion in Purine Nucleoside Phosphorylase Deficiency. Archives of Disease in Childhood, 62, 385\u2013391. https:\/\/doi.org\/10.1136\/ADC.62.4.385","journal-title":"Archives of Disease in Childhood"},{"key":"10821_CR97","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/BF01800045","volume":"10","author":"LD Fairbanks","year":"1987","unstructured":"Fairbanks, L. D., Simmonds, H. A., & Webster, D. R. (1987). Use of Intact erythrocytes in the diagnosis of inherited Purine and Pyrimidine disorders. Journal of Inherited Metabolic Disease, 10, 174\u2013186. https:\/\/doi.org\/10.1007\/BF01800045","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"10821_CR98","doi-asserted-by":"publisher","unstructured":"Shiro Seto Carlos, L., Bruce Wasson, C. D., Carson Scripps Clinic, D. A., Shewach, S., Mitchell, B. S., Simkin, P. A., Benedict, R. S., Shin, Y. S., Reiter, S., Anne Simmonds, H. (1985). Z-Nucleotide accumulation in erythrocytes from Lesch-Nyhan patients: 190. Pediatric Research 1985 19:7 19, 775\u2013775, https:\/\/doi.org\/10.1203\/00006450-198507000-00210","DOI":"10.1203\/00006450-198507000-00210"},{"key":"10821_CR99","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1007\/BF00484533","volume":"16","author":"SD Skaper","year":"1978","unstructured":"Skaper, S. D., & Schafer, I. A. (1978). Monoamino Oxidase Activity reduced in cultured human fetal cells deficient in hypoxanthine-guanine phosphoribosyltransferase activity. Biochemical Genetics, 16, 1135\u20131138. https:\/\/doi.org\/10.1007\/BF00484533","journal-title":"Biochemical Genetics"},{"key":"10821_CR100","doi-asserted-by":"publisher","first-page":"5596","DOI":"10.1016\/S0021-9258(18)45615-3","volume":"262","author":"MA Becker","year":"1987","unstructured":"Becker, M. A., Losman, M. J., & Kim, M. (1987). Mechanisms of accelerated purine nucleotide synthesis in human fibroblasts with superactive phosphoribosylpyrophosphate synthetases. Journal of Biological Chemistry, 262, 5596\u20135602. https:\/\/doi.org\/10.1016\/S0021-9258(18)45615-3","journal-title":"Journal of Biological Chemistry"},{"key":"10821_CR101","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/J.1471-4159.1993.TB02146.X","volume":"61","author":"E Zoref-Shani","year":"1993","unstructured":"Zoref-Shani, E., Bromberg, Y., Brosh, S., Sidi, Y., & Sperling, O. (1993). Characterization of the alterations in Purine Nucleotide Metabolism in Hypoxanthine-Guardne phosphoribosyltransferase-deficient rat Neuroma Cell line. Journal of Neurochemistry, 61, 457\u2013463. https:\/\/doi.org\/10.1111\/J.1471-4159.1993.TB02146.X","journal-title":"Journal of Neurochemistry"},{"key":"10821_CR102","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/JNC.12366","volume":"127","author":"M G\u00f6ttle","year":"2013","unstructured":"G\u00f6ttle, M., Burhenne, H., Sutcliffe, D., & Jinnah, H. A. (2013). Purine metabolism during neuronal differentiation: The relevance of Purine Synthesis and Recycling. Journal of Neurochemistry, 127, 805\u2013818. https:\/\/doi.org\/10.1111\/JNC.12366","journal-title":"Journal of Neurochemistry"},{"key":"10821_CR103","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/j.neuroscience.2007.10.065","volume":"152","author":"JC Lewers","year":"2008","unstructured":"Lewers, J. C., Ceballos-Picot, I., Shirley, T. L., Mockel, L., Egami, K., & Jinnah, H. A. (2008). Consequences of impaired purine recycling in dopaminergic neurons. Neuroscience, 152, 761\u2013772. https:\/\/doi.org\/10.1016\/j.neuroscience.2007.10.065","journal-title":"Neuroscience"},{"key":"10821_CR104","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/J.1471-4159.1986.TB02837.X","volume":"47","author":"CM Bitler","year":"1986","unstructured":"Bitler, C. M., & Howard, B. D. (1986). Dopamine metabolism in hypoxanthine-guanine phosphoribosyltransferase-deficient variants of PC12 cells. Journal of Neurochemistry, 47, 107\u2013112. https:\/\/doi.org\/10.1111\/J.1471-4159.1986.TB02837.X","journal-title":"Journal of Neurochemistry"},{"key":"10821_CR105","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1159\/000449296","volume":"7","author":"S Bell","year":"2016","unstructured":"Bell, S., Kolobova, I., Crapper, L., & Ernst, C. (2016). Lesch-Nyhan Syndrome: Models, theories, and therapies. Molecular Syndromology, 7, 302\u2013311. https:\/\/doi.org\/10.1159\/000449296","journal-title":"Molecular Syndromology"},{"key":"10821_CR106","doi-asserted-by":"publisher","unstructured":"Antonov, S. A., & Novosadova, E. V. (2021). Current state-of-the-art and unresolved problems in using Human Induced Pluripotent Stem cell-derived dopamine neurons for Parkinson\u2019s Disease Drug Development. International Journal of Molecular Sciences, 22. https:\/\/doi.org\/10.3390\/IJMS22073381","DOI":"10.3390\/IJMS22073381"},{"key":"10821_CR107","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1073\/PNAS.0910012107\/SUPPL_FILE\/PNAS.200910012SI.PDF","volume":"107","author":"BY Hu","year":"2010","unstructured":"Hu, B. Y., Weick, J. P., Yu, J., Ma, L. X., Zhang, X. Q., Thomson, J. A., & Zhang, S. C. (2010). Neural differentiation of Human Induced Pluripotent stem cells follows Developmental principles but with variable potency. Proc Natl Acad Sci U S A, 107, 4335\u20134340. https:\/\/doi.org\/10.1073\/PNAS.0910012107\/SUPPL_FILE\/PNAS.200910012SI.PDF","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10821_CR108","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/J.STEM.2016.04.013","volume":"18","author":"D Hockemeyer","year":"2016","unstructured":"Hockemeyer, D., & Jaenisch, R. (2016). Induced Pluripotent stem cells Meet Genome Editing. Cell Stem Cell, 18, 573\u2013586. https:\/\/doi.org\/10.1016\/J.STEM.2016.04.013","journal-title":"Cell Stem Cell"},{"key":"10821_CR109","doi-asserted-by":"publisher","first-page":"212493","DOI":"10.3389\/FNMOL.2016.00078\/BIBTEX","volume":"9","author":"S Barral","year":"2016","unstructured":"Barral, S., & Kurian, M. A. (2016). Utility of Induced Pluripotent Stem cells for the study and treatment of genetic diseases: Focus on Childhood Neurological disorders. Frontiers in Molecular Neuroscience, 9, 212493. https:\/\/doi.org\/10.3389\/FNMOL.2016.00078\/BIBTEX","journal-title":"Frontiers in Molecular Neuroscience"},{"key":"10821_CR110","doi-asserted-by":"publisher","unstructured":"Kitamura, R. A., Maxwell, K. G., Ye, W., Kries, K., Brown, C. M., Augsornworawat, P., Hirsch, Y., Johansson, M. M., Weiden, T., Ekstein, J., et al. (2022). Multidimensional analysis and Therapeutic Development using patient IPSC\u2013Derived Disease models of Wolfram Syndrome. JCI Insight, 7. https:\/\/doi.org\/10.1172\/JCI.INSIGHT.156549","DOI":"10.1172\/JCI.INSIGHT.156549"},{"key":"10821_CR111","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.3390\/MOLECULES25143145","volume":"25","author":"ML Tran","year":"2020","unstructured":"Tran, M. L., G\u00e9nisson, Y., Ballereau, S., & Dehoux, C. (2020). Second-generation pharmacological chaperones: Beyond inhibitors. Molecules 2020, 25,, 3145. https:\/\/doi.org\/10.3390\/MOLECULES25143145","journal-title":"Molecules 2020"},{"key":"10821_CR112","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0022-510X(74)90245-7","volume":"22","author":"RO McKeran","year":"1974","unstructured":"McKeran, R. O., Howell, A., Andrews, T. M., Watts, R. W. E., & Arlett, C. F. (1974). Observations on the growth in Vitro of myeloid progenitor cells and fibroblasts from Hemizygotes and heterozygotes for complete and partial hypoxanthine-guanine phosphoribosyltransferase (HGPRT) Deficiency, and their relevance to the pathogenesis of brain damage in the Lesch-Nyhan Syndrome. Journal of the Neurological Sciences, 22, 183\u2013195. https:\/\/doi.org\/10.1016\/0022-510X(74)90245-7","journal-title":"Journal of the Neurological Sciences"},{"key":"10821_CR113","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/978-1-4615-9140-5_59","volume":"122A","author":"J Allsop","year":"1980","unstructured":"Allsop, J., & Watts, R. W. (1980). Activities of Amidophosphoribosyltransferase and Purine Phosphoribosyltransferases in developing rat brain. Advances in Experimental Medicine and Biology, 122A, 361\u2013366. https:\/\/doi.org\/10.1007\/978-1-4615-9140-5_59","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"10821_CR114","doi-asserted-by":"publisher","unstructured":"L\u00f3pez, J. M., Outtrim, E. L., Fu, R., Sutcliffe, D. J., Torres, R. J., & Jinnah, H. A. (2020). Physiological levels of folic acid reveal purine alterations in Lesch-Nyhan Disease. Proc Natl Acad Sci USA, 117. https:\/\/doi.org\/10.1073\/PNAS.2003475117","DOI":"10.1073\/PNAS.2003475117"},{"key":"10821_CR115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S10020-023-00774-8\/FIGURES\/8","volume":"30","author":"P Escudero-Ferruz","year":"2024","unstructured":"Escudero-Ferruz, P., Ontiveros, N., Cano-Estrada, C., Sutcliffe, D. J., Jinnah, H. A., Torres, R. J., & L\u00f3pez, J. M. (2024). A new physiological medium uncovers biochemical and Cellular alterations in Lesch-Nyhan Disease fibroblasts. Molecular Medicine, 30, 1\u201320. https:\/\/doi.org\/10.1186\/S10020-023-00774-8\/FIGURES\/8","journal-title":"Molecular Medicine"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-024-10821-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-024-10821-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-024-10821-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T05:19:35Z","timestamp":1740806375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-024-10821-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,4]]},"references-count":115,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10821"],"URL":"https:\/\/doi.org\/10.1007\/s12015-024-10821-4","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,4]]},"assertion":[{"value":"29 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare that they have no conflict of interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not Applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All authors approved the submission of the article.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}